Upgrade to SI Premium - Free Trial

PDS Biotechnology (PDSB)

1.24 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/12/26)

Latest Headlines

Form 4 PDS Biotechnology Corp For: Oct 18 Filed by: Dawson John Andrew October 21, 2026 6:42 PM - SEC Filing Form 3 PDS Biotechnology Corp For: Oct 18 Filed by: Dawson John Andrew October 21, 2026 6:40 PM - SEC Filing Form 8-K PDS Biotechnology Corp For: Oct 20 October 21, 2026 6:02 AM - SEC Filing Form 4 PDS Biotechnology Corp For: Oct 18 Filed by: Ramsdell Deborah October 20, 2026 8:21 PM - SEC Filing Form 4 PDS Biotechnology Corp For: Oct 18 Filed by: Wendel Bruce October 20, 2026 8:20 PM - SEC Filing Form 3 PDS Biotechnology Corp For: Oct 18 Filed by: Wendel Bruce October 20, 2026 8:16 PM - SEC Filing Form 3 PDS Biotechnology Corp For: Oct 18 Filed by: Ramsdell Deborah October 20, 2026 8:16 PM - SEC Filing Form 8-K PDS Biotechnology Corp For: Oct 18 October 20, 2026 8:01 AM - SEC Filing PDS Biotech adds three directors amid four board resignations October 20, 2026 8:00 AM - StreetInsider PDS Biotechnology Appoints Three Accomplished Pharma Industry Executives to Board of Directors October 20, 2026 8:00 AM - StreetInsider Form S-3 PDS Biotechnology Corp October 14, 2026 4:17 PM - SEC Filing Form 8-K PDS Biotechnology Corp For: Oct 06 October 6, 2026 8:06 AM - SEC Filing PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases October 6, 2026 8:00 AM - StreetInsider Form 8-K PDS Biotechnology Corp For: Sep 12 September 22, 2026 5:10 PM - SEC Filing Form 8-K PDS Biotechnology Corp For: Sep 22 September 22, 2026 8:05 AM - SEC Filing PDS Biotech publishes phase 2 head and neck cancer trial results September 22, 2026 8:00 AM - StreetInsider PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncolog September 22, 2026 8:00 AM - StreetInsider Form SCHEDULE 13D PDS Biotechnology Corp Filed by: Nant Capital, LLC September 21, 2026 9:56 PM - SEC Filing Form 3 PDS Biotechnology Corp For: Sep 14 Filed by: SOON-SHIONG PATRICK September 21, 2026 8:40 PM - SEC Filing Form 3 PDS Biotechnology Corp For: Sep 14 Filed by: Banaag Arnold James September 21, 2026 8:39 PM - SEC Filing Form 8-K PDS Biotechnology Corp For: Sep 21 September 21, 2026 4:06 PM - SEC Filing Form 3 PDS Biotechnology Corp For: Sep 12 Filed by: Trochimiuk Janetta September 18, 2026 4:34 PM - SEC Filing Form 8-K PDS Biotechnology Corp For: Sep 12 September 14, 2026 4:11 PM - SEC Filing PDS Biotech closes $11.3M PIPE led by Nant Capital, adds Soon-Shiong September 14, 2026 10:30 AM - StreetInsider PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors September 14, 2026 10:30 AM - StreetInsider PDS Biotech raises $22.55M in PIPE led by NantWorks founder September 8, 2026 8:32 AM - StreetInsider PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks September 8, 2026 8:30 AM - StreetInsider Form 8-K PDS Biotechnology Corp For: Aug 21 August 25, 2026 4:08 PM - SEC Filing Form 8-K PDS Biotechnology Corp For: Aug 13 August 19, 2026 4:52 PM - SEC Filing Form 8-K PDS Biotechnology Corp For: Aug 10 August 14, 2026 8:01 AM - SEC Filing PDS Biotechnology Corp (PDSB) PT Lowered to $7 at H.C. Wainwright August 14, 2026 6:49 AM - StreetInsider Form 10-Q PDS Biotechnology Corp For: Jun 30 August 13, 2026 4:20 PM - SEC Filing Form 8-K PDS Biotechnology Corp For: Aug 13 August 13, 2026 8:36 AM - SEC Filing PDS Biotech Reports Second Quarter 2026 Financial Results August 13, 2026 8:30 AM - StreetInsider Form 8-K PDS Biotechnology Corp For: Aug 11 August 11, 2026 8:31 AM - SEC Filing PDS Biotech shifts focus to PDS0301 in colorectal cancer August 11, 2026 8:25 AM - StreetInsider PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101 August 11, 2026 8:25 AM - StreetInsider Form 8-K PDS Biotechnology Corp For: Jul 30 July 31, 2026 4:16 PM - SEC Filing Full Article List